329- Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-
disordered breathing and hypertension. N Engl J Med. 2000;342:1378–84. - Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and hyperten-
sion. A population-based study. Ann Intern Med. 1994;120(5):382–8. - Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh
report of the Joint National Committee on prevention, detection, evaluation, and treatment of
high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–72. - Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension:
diagnosis, evaluation, and treatment. A scientific statement from the American Heart
Association professional education Committee of the Council for high blood pressure research.
Hypertension. 2008;51:1403–19. - Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al.
Reappraisal of European guidelines on hypertension management: a European Society of
Hypertension Task Force document. Blood Press. 2009;18:308–47. - Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ, et al. Association between treated
and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012;307:2169–76. - O’Connor GT, Caffo B, Newman AB, et al. Prospective study of the association between
sleep-disordered breathing and hypertension: the sleep Heart health study. Am J Respir Crit
Care Med. 2009;179(12):1159–64. - Baguet JP, Hammer L, Levy P, Pierre H, Rossini E, Mouret S, Ormezzano O, Mallion JM,
Pepin JL. Night-time and diastolic hypertension are common and underestimated conditions in
newly diagnosed apnoeic patients. J Hypertens. 2005;23:521–7. - Hla KM, Young T, Finn L, Peppard PE, Szklo-Coxe M, Stubbs M. Longitudinal association of
sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin sleep
cohort study. Sleep. 2008;31:795–800. - Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, et al. High preva-
lence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens.
2001;19:2271–7. - Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, et al. Obstructive
sleep apnea: the most common secondary cause of hypertension associated with resistant
hypertension. Hypertension. 2011;58:811–7. - Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report
of the Joint National Committee on prevention, detection, evaluation, and treatment of high
blood pressure. Hypertension. 2003;42:1206–52. - Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 guide-
lines for the Management of Arterial Hypertension: the task force for the management of arte-
rial hypertension of the European Society of Hypertension and the European Society of
Cardiology. J Hypertens. 2007;25:1105–87. - Loredo JS, Ancoli-Israel S, Dimsdale JE. Sleep quality and blood pressure dipping in obstruc-
tive sleep apnea. Am J Hypertens. 2001;14:887–92. - Yu HT. Progression of chronic renal failure. Arch Intern Med. 2003;163:1417–29.
- Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive
drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA.
2002;288:2421–31. - Abdel-Kader K, Dohar S, Shah N, et al. Resistant hypertension and obstructive sleep apnea in
the setting of kidney disease. J Hypertens. 2012;30:960–6. - Kraus MA, Hamburger RJ. Sleep apnea in renal failure. Adv Perit Dial. 1997;13:88–92.
- Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, et al. Plasma aldosterone is related to
severity of obstructive sleep apnea in subjects with resistant hypertension. Chest.
2007;131:453–9. - Calhoun DA, Nishizaka MK, Zaman MA, Harding SM. Aldosterone excretion among subjects
with resistant hypertension and symptoms of sleep apnea. Chest. 2004;125(1):112–7.
20 The Effect of CPAP Therapy on Resistant Hypertension in Obstructive Sleep...